Dr Agarwal's Eye Hospital Ltd
Ticker: DRAGARWQ
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
5081.40
Market Cap
2388.26
Debt/Equity
1.5894
ROE %
29.802
PB
11.3938
Promoter %
71.897
Pledge %
39.865
1Y Rev Growth %
24.045
5Y Rev Growth %
17.631
NP Margin %
13.586
NP Margin 5Y Avg %
10.491
Trading Reference
1M Return %
6.941
6M Return %
23.030
1Y Return %
-3.393
% Away 52W High
43.661
% Away 52W Low
45.183
Daily Volume
1451
Investment Verdict
Risky
Score 49/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 52/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Dr Agarwal's Eye Hospital Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock maintains above this support, there is a strong probability of reaching the resistance level within the next 6-12 months. However, a break below the support could lead to a significant decline.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
I
ICICI Prudential Nifty 50 ETF
The ICICI Prudential Nifty 50 ETF presents a decent investment opportunity with a diversified portfolio and consistent growth metrics, but investors should be cautious of market volatility.
View details
S
SG Finserve Ltd
SG Finserve Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
D
DCW Ltd
DCW Ltd shows potential in a stable sector but faces challenges in growth consistency and market sentiment.
View details
V
Veranda Learning Solutions Ltd
Veranda Learning Solutions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Precision Camshafts Ltd
Precision Camshafts Ltd shows potential but faces significant challenges in growth and profitability. Investors should be cautious.
View details
A
Apcotex Industries Ltd
Apcotex Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
S
Steelcast Ltd
Steelcast Ltd shows potential in a crucial sector with decent growth prospects, but faces challenges in profitability consistency and market sentiment.
View details
R
Rane Holdings Ltd
Rane Holdings Ltd presents a mixed investment case with decent fundamentals but notable risks in execution and market sentiment.
View details
I
India Nippon Electricals Ltd
India Nippon Electricals Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
M
MSP Steel & Power Ltd
MSP Steel & Power Ltd shows potential but faces significant challenges that could impact future performance.
View details
B
Bharat Global Developers Ltd
Bharat Global Developers Ltd has potential but faces challenges in growth consistency and profitability. Investors should proceed with caution.
View details
C
Cantabil Retail India Ltd
Cantabil Retail India Ltd shows potential but faces significant challenges in growth and profitability. Caution is advised.
View details
K
Kalyani Investment Company Ltd
Kalyani Investment Company Ltd presents several risks with limited growth prospects and inconsistent financial performance, making it a risky investment.
View details
A
Accelya Solutions India Ltd
Accelya Solutions shows potential but faces challenges in growth consistency and market competition.
View details
V
Venky's (India) Ltd
Venky's (India) Ltd shows potential but faces significant challenges in growth consistency and market competition.
View details
G
Grand Oak Canyons Distillery Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
Business Overview
Dr Agarwal's Eye Hospital Ltd is a leading eye care provider in India, renowned for its advanced treatments and patient-centric approach. Catering to individuals seeking quality eye care, the hospital combines expertise with cutting-edge technology to deliver exceptional outcomes. With a commitment to accessibility and affordability, it plays a vital role in improving the vision health of millions. Trust in their experienced team and comprehensive services for all your eye care needs.
- Established leader in eye care
- Advanced technology and treatments
- Patient-centric approach
- Accessible and affordable services
- Experienced medical professionals
- Nationwide presence for convenience
Investment Thesis
Dr Agarwal's Eye Hospital Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company is well-positioned to capitalize on the increasing demand for eye care in India.
- Strong promoter group with a proven track record in healthcare.
- Robust growth in digital services enhancing patient engagement and operational efficiency.
- Valuation remains attractive compared to industry peers, offering potential upside.
- Expanding network of hospitals catering to rising demand for eye care.
- Focus on quality and innovation reinforces brand reputation and trust.
Opportunity vs Risk
Opportunities
- Growing demand for eye care services
- Expansion into tier-2 cities
- Technological advancements in treatments
- Strong brand recognition
- Increasing health awareness among consumers
Risks ⚠️
- Regulatory changes in healthcare
- Intense competition from other hospitals
- Economic downturn affecting discretionary spending
- High operational costs
- Dependence on skilled professionals
Peer Perspective
Dr Agarwal's Eye Hospital Ltd trades at a premium compared to peers like Narayana Hrudayalaya and Fortis Healthcare, reflecting its strong growth potential. A focus on margin stability could trigger a rerating in the stock.
Future Outlook
Dr Agarwal's Eye Hospital Ltd is well-positioned for growth, driven by expanding demand for eye care services. Successful execution of its strategic initiatives and effective cost control will be crucial for maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Dr Agarwal's Eye Hospital Ltd do?A: It provides eye care services, including surgeries and treatments, across multiple locations in India.
- Q: Is Dr Agarwal's Eye Hospital Ltd listed on stock exchanges?A: Yes, it is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in India.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and overall industry trends in healthcare.
- Q: How can I track the performance of this stock?A: You can track its performance through stock market apps, financial news websites, or brokerage platforms.
- Q: Are there any risks involved in investing in this stock?A: Like all investments, risks include market volatility, regulatory changes, and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Dr Agarwal's Eye Hospital Ltd • Updated: 2025-09-17 01:54:08
-
10BusinessHighThe healthcare sector is growing, but competition is increasing.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are higher than peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is stable, but some concerns over disclosures.
-
5DriversGoodGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Dr Agarwal's Eye Hospital Ltd shows potential for growth, but faces challenges in profitability and valuation metrics compared to peers.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100